 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summaries
Moderna
MRNA
conference date: November 6, 2025 @ 5:00 AM Pacific Time
Moderna After COVID Vaccine Bolus July 19, 2022 @ Seeking Alpha
Moderna: $30 Billion Market Capitalization is Rich July 29, 2020 @ Seeking Alpha
Moderna: mRNA Therapy Potential Worth Accumulating March 14, 2019 @ Seeking Alpha
| 2025 | |||
| Moderna Q4 2024 |
Moderna Q1 2025 |
Moderna Q2 2025 |
Moderna Q3 2025 |
| Feb. 14, 2025 | May 1, 2025 | August 1, 2025 | Nov. 6, 2025 |
| 2024 | |||
| Moderna Q4 2023 |
Moderna Q1 2024 |
Moderna Q2 2024 |
Moderna Q3 2024 |
| Feb. 22, 2024 | May 2, 2024 | Aug. 1, 2024 | Nov. 7, 2024 |
| 2023 | |||
| Moderna Q4 2022 |
Moderna Q1 2023 |
Moderna Q2 2023 |
Moderna Q3 2023 |
| Feb. 23, 2023 | May 4, 2023 | Aug. 3, 2023 | Nov. 2, 2023 |
| 2022 | |||
| Moderna Q4 2021 |
Moderna Q1 2022 |
Moderna Q2 2022 |
Moderna Q3 2022 |
| Feb. 24, 2022 | May 4, 2022 | August 3, 2022 | Nov. 3, 2022 |
| 2021 | |||
| Moderna Q4 2020 |
Moderna Q1 2021 |
Moderna Q2 2021 |
Moderna Q3 2021 |
| Feb. 25, 2021 | May 6, 2021 | Aug. 5, 2021 | Nov. 4, 2021 |
| 2020 | |||
| Moderna Q4 2019 |
Moderna Q1 2020 |
Moderna Q2 2020 |
Moderna Q3 2020 |
| Feb. 26, 2020 | May 7, 2020 | Aug. 5, 2020 | Oct. 29, 2020 |
| 2019 | |||
| Moderna Q4 2018 |
Moderna Q1 2019 |
Moderna Q2 2019 |
Moderna Q3 2019 |
| March 6, 2019 | May 8, 2019 | August 7, 2019 | Nov. 6, 2019 |
Moderna (MRNA) is a clinical-stage biotechnology company specializing in RNA based therapies.
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALLO |
| ALNY |
| AMAT |
| AMGN |
| APRE |
| ARWR |
| BIIB |
| BMY |
| CLDX |
| CDTX |
| FATE |
| GILD |
| GLYC |
| ILMN |
| INO |
| IONS |
| MCHP |
| PLX |
| REGN |
| RNA |
| RXRX |
| SAGE |
| SANA |
| VRTX |
| VSTM |
| WBA |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2025 William P. Meyers